AzTrials
AzTrials

Migraine DisordersNCT03772860

Defining the Sympathetic Skin Response of Migraineurs in the Facial Area

An observational study of Migraine Disorders, run by Hillel Yaffe Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to define the sympathetic skin response of migraineurs in the facial area. This will be achieved by exposing healthy volunteers and migraine patients to various stress stimuli (pain, visual stimulation, auditory stimulation and a mathematical challenge), and recording sympathetic skin response… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Migraine Disorders
What is being tested?
Pain stimulation, Visual stimulation and Auditory stimulation
How many people
70 participants
Where
1 siteIsrael
Study dates
Dec 2018to Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients suffering migraine attending our Neurology Clinic and healthy volunteers

Who may be able to join

  • Healthy volunteers with no history of any kind of recurrent headache
  • Migraine patients according to ICH3 criteria
  • Migraine patients with more than 1 attack per month

Who cannot join

  • Patients with other heart or neurologic diseases
  • Patients with hearing or visual decline
  • Patients taking medication that effects the sympathetic system (except those taking beta blockers for migraine treatment)

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Hillel Yaffe Medical Center

    Hadera, 38100

    Erel Domany, MD, erel.domany@gmail.com

Other trials in Israel

About this study

Official title: Defining the Sympathetic Skin Response of Migraineurs in the Facial Area During the Interictal State: Comparison of Migraine Patients Who Suffer Dominant Left/Right/Bilateral Pain.

The aim of this study is to define the sympathetic skin response of migraineurs in the facial area. This will be achieved by exposing healthy volunteers and migraine patients to various stress stimuli (pain, visual stimulation, auditory stimulation and a mathematical challenge), and recording sympathetic skin response in the facial area.

Being tested
Pain stimulation, Visual stimulation, Auditory stimulation, Mental stress
Medical subject headings
Migraine Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain stimulationOther

    Pain will be simulated with an electric shock 25 mlAMP over the median nerve

  • Visual stimulationOther

    Visual stimulation will be performed by a flicker of light on a computer screen at 15 Hrz for 0.3 seconds

  • Auditory stimulationOther

    Auditory stimulation will be delivered through headphones with a sound at 500 Hrz at 85 decibels for 0.3 seconds

  • Mental stressOther

    A mathematical challenge will be displayed on a computer screen that must be quickly solved

Study groups in NCT03772860
Study groupRoleWhat they receive
Healthy volunteersHealthy volunteers will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
Receives: Other: Pain stimulation; Other: Visual stimulation; Other: Auditory stimulation; Other: Mental stress
Left headacheMigraine patients with mostly left sided headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
Receives: Other: Pain stimulation; Other: Visual stimulation; Other: Auditory stimulation; Other: Mental stress
Right headacheMigraine patients with mostly right sided headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
Receives: Other: Pain stimulation; Other: Visual stimulation; Other: Auditory stimulation; Other: Mental stress
Bilateral headacheMigraine patients without a dominant side headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
Receives: Other: Pain stimulation; Other: Visual stimulation; Other: Auditory stimulation; Other: Mental stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Defining sympathetic skin response in migraineurs

    Outcome will be presented as mean sympathetic response values for all the different stimuli and then separately for each stimuli

    Measured: One year

Secondary outcomes (1)
  1. Defining differences between sympathetic skin response in migraineurs

    Outcome will be presented as mean sympathetic response values for all the different stimuli and then separately for each stimuli

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2018
  2. Study startDec 2018 (estimated)
  3. Primary completionDec 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03772860
Sponsor's protocol ID
HYMC-113-18
Status last verified
Dec 2018
First submitted
5 Dec 2018
Last updated
11 Dec 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Migraine Disorders, run by Hillel Yaffe Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Erel Domany, MD (972-52-6134235, erel.domany@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Defining sympathetic skin response in migraineurs (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in